Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis

On­col­o­gists are en­cour­aged by the num­ber of im­munother­a­pies to treat non-small cell lung can­cer, but they still want more op­tions, es­pe­cial­ly for ad­vanced cas­es, ac­cord­ing

Patients with highly active systemic lupus erythematosus (SLE) appeared to sustain much less organ damage and fewer disease flares when drug therapy yielded substantial relief,